Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : McNeil AB (Johnson & Johnson Consumer and Personal Products Worldwide, J&J CPPW)

Femme et Homme Max 99 ans
McNeil AB (Johnson & Johnson Consumer and Personal Products Worldwide, J&J CPPW) MAJ Il y a 4 ans

Efficacy and safety following use of a novel nicotine replacement therapy. A multicenter, randomized, double blind, placebo-controlled, parallel group, 52-week study in smokers motivated to quit To evaluate the efficacy of NMS versus placebo in smokers to achieve continuous abstinence from smoking from the week 2 visit until and including the week 6, week 24, and week 52 visits, respectively.

Pays Aucun
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations